-
1
-
-
0036271290
-
Systemic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion
-
Carless PA, Anthony DM, Henry DA. Systemic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002; 89: 695-703
-
(2002)
Br J Surg
, vol.89
, pp. 695-703
-
-
Carless, P.A.1
Anthony, D.M.2
Henry, D.A.3
-
2
-
-
0020430667
-
Fibrin adhesive: An important hemostatic adjunct in cardiovascular operations
-
Borst HG, Haverich A, Walterbusch G et al. Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 1982; 84: 548-553
-
(1982)
J Thorac Cardiovasc Surg
, vol.84
, pp. 548-553
-
-
Borst, H.G.1
Haverich, A.2
Walterbusch, G.3
-
3
-
-
0025302617
-
Four years' experience with fibrin sealant in thoracic and cardiovascular surgery
-
Mathew TL, Spotnitz WD, Kron IL et al. Four years' experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 1990; 50: 40-44
-
(1990)
Ann Thorac Surg
, vol.50
, pp. 40-44
-
-
Mathew, T.L.1
Spotnitz, W.D.2
Kron, I.L.3
-
4
-
-
0028145080
-
Aortic valve repair with fibrin glue for type A acute aortic dissection
-
Seguin JR, Picard E, Frapier JM, Chaptal PA. Aortic valve repair with fibrin glue for type A acute aortic dissection. Ann Thorac Surg 1994; 58: 304-307
-
(1994)
Ann Thorac Surg
, vol.58
, pp. 304-307
-
-
Seguin, J.R.1
Picard, E.2
Frapier, J.M.3
Chaptal, P.A.4
-
5
-
-
0030903558
-
Fibrin sealant: Scientific rationale, production methods, properties and current clinical use
-
Radosevich M, Goubran HA, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties and current clinical use. Vox Sang 1997; 72: 133-143
-
(1997)
Vox Sang
, vol.72
, pp. 133-143
-
-
Radosevich, M.1
Goubran, H.A.2
Burnouf, T.3
-
6
-
-
0034801567
-
Fibrin sealants in surgical practice: An overview
-
Jackson MR. Fibrin sealants in surgical practice: An overview. Am J Surg 2001, 182 (Suppl): 1S-7S
-
(2001)
Am J Surg
, vol.182
, Issue.SUPPL.
-
-
Jackson, M.R.1
-
7
-
-
0034815918
-
Commercial fibrin sealants in surgical care
-
Spotnitz WD. Commercial fibrin sealants in surgical care. Am J Surg 2001; 182 (Suppl): S8-14
-
(2001)
Am J Surg
, vol.182
, Issue.SUPPL.
-
-
Spotnitz, W.D.1
-
8
-
-
0036209535
-
Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery
-
Kawamura M, Sawafuji M, Watanabe M, et al. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002; 73: 1098-1100
-
(2002)
Ann Thorac Surg
, vol.73
, pp. 1098-1100
-
-
Kawamura, M.1
Sawafuji, M.2
Watanabe, M.3
-
9
-
-
0031692295
-
Vivostat system autologous fibrin sealant: Preliminary study in elective coronary bypass grafting
-
Kjaergard HK, Trumbull HR. Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 1998; 66: 482-486
-
(1998)
Ann Thorac Surg
, vol.66
, pp. 482-486
-
-
Kjaergard, H.K.1
Trumbull, H.R.2
-
10
-
-
0035170319
-
The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery
-
Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plastic Reconstr Surg 2001; 107: 229-239
-
(2001)
Plastic Reconstr Surg
, vol.107
, pp. 229-239
-
-
Man, D.1
Plosker, H.2
Winland-Brown, J.E.3
-
11
-
-
0343811706
-
Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery
-
Fang WC, Helm RE, Krieger KH, et al. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997; 96 (Suppl 11): 11-194-199
-
(1997)
Circulation
, vol.96
, Issue.SUPPL. 11
, pp. 11-194
-
-
Fang, W.C.1
Helm, R.E.2
Krieger, K.H.3
-
12
-
-
0030341759
-
Controlled clinical studies of fibrin sealant in cardiovascular surgery: A review
-
Kjaergard HK, Fairbrother JE. Controlled clinical studies of fibrin sealant in cardiovascular surgery: a review. Eur J Cardiothorac Surg 1996; 10: 727-733
-
(1996)
Eur J Cardiothorac Surg
, vol.10
, pp. 727-733
-
-
Kjaergard, H.K.1
Fairbrother, J.E.2
-
13
-
-
0034801306
-
The role of fibrin sealants in hemostasis
-
Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg 2001; 182: 21S-28S
-
(2001)
Am J Surg
, vol.182
-
-
Mankad, P.S.1
Codispoti, M.2
-
14
-
-
0030960731
-
Reoperations for bleeding after coronary artery bypass procedures during 25 years
-
Sellman M, Intonti MA, Ivert L. Reoperations for bleeding after coronary artery bypass procedures during 25 years. Eur J Cardiothoracic Surg 1997; 11: 521-527
-
(1997)
Eur J Cardiothoracic Surg
, vol.11
, pp. 521-527
-
-
Sellman, M.1
Intonti, M.A.2
Ivert, L.3
-
15
-
-
0030308371
-
Autalogous platelet sequestration in patients undergoing coronary artery bypass grafting. A prospective randomized study
-
Christenson JT, Reuse J, Badel P et al. Autalogous platelet sequestration in patients undergoing coronary artery bypass grafting. A prospective randomized study. Eur J Cardiothorac Surg 1996; 10: 1083-1089
-
(1996)
Eur J Cardiothorac Surg
, vol.10
, pp. 1083-1089
-
-
Christenson, J.T.1
Reuse, J.2
Badel, P.3
-
16
-
-
0029125992
-
Fibrin sealant in the United States: Clinical use at the University of Virginia
-
Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 1995; 47: 482-485
-
(1995)
Thromb Haemost
, vol.47
, pp. 482-485
-
-
Spotnitz, W.D.1
-
17
-
-
0029128568
-
Fibrin sealant reduces suture line bleeding during carotid endarterectomy: A randomized trial
-
Milne AA, Murphy WG, Reading SJ, Ruckley CV. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomized trial. Eur J Endovasc Surg 1995; 10: 91-94
-
(1995)
Eur J Endovasc Surg
, vol.10
, pp. 91-94
-
-
Milne, A.A.1
Murphy, W.G.2
Reading, S.J.3
Ruckley, C.V.4
-
18
-
-
0031968379
-
Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease
-
Schuele AM, Beierlein MS, Wendel HP et al. Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease. J Thorac Cardiovasc Surg 1998; 115: 883-889
-
(1998)
J Thorac Cardiovasc Surg
, vol.115
, pp. 883-889
-
-
Schuele, A.M.1
Beierlein, M.S.2
Wendel, H.P.3
-
19
-
-
0028073163
-
Autologous fibrin glue: The last step in operative hemostasis
-
Tawes RL Jr, Sydorak GR, DuVall TB. Autologous fibrin glue: the last step in operative hemostasis. Am J Surg 1994; 168: 120-122
-
(1994)
Am J Surg
, vol.168
, pp. 120-122
-
-
Tawes Jr., R.L.1
Sydorak, G.R.2
DuVall, T.B.3
-
20
-
-
0025894052
-
Role of platelet derived growth factor in wound healing
-
Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet derived growth factor in wound healing. J Cell Biochem 1991; 45: 319-326
-
(1991)
J Cell Biochem
, vol.45
, pp. 319-326
-
-
Pierce, G.F.1
Mustoe, T.A.2
Altrock, B.W.3
Deuel, T.F.4
Thomason, A.5
|